Skip to main content
. 2013 Jul 2;8(7):e67118. doi: 10.1371/journal.pone.0067118

Figure 4. Effects of melatonin on NMU mRNA expression in the PT, PD, and SCN.

Figure 4

(A–D) Microphotograph of NMU mRNA expression detected by ISH in the PT of control and melatonin-treated groups at ZT6 and ZT18. (A, B) Staining signal in the PT was decreased in the melatonin-treated group compared to the sham group at ZT6. (C, D) In the ZT18 samples, a similar staining intensity was observed in the sham and melatonin-treated groups. Scale bar: 200 µm. PT, pars tuberalis; ARC, arcuate nucleus; 3V, third ventricle. (E) qPCR analysis of NMU in the PT was performed for the sham and melatonin groups at ZT6 and ZT18 using LMD samples. Two-way ANOVA revealed a significant interaction between melatonin treatment and time point (P<0.05) and that the NMU mRNA expression level of the ZT6 melatonin group was significantly higher than that of the ZT6 melatonin, ZT18 control, and ZT18 melatonin groups (one way ANOVA, P<0.01). (F, G) qPCR analysis for NMU in the SCN and PD performed for the sham and melatonin-treated rats at ZT6 and ZT18. NMU mRNA expression in the SCN and PD were considerably lower and not influenced by time or melatonin treatment.